<?xml version="1.0" encoding="UTF-8"?>
<ack>
 <title>Acknowledgements</title>
 <p>The authors thank all members of the Shi lab and colleagues at University of Texas Medical Branch (UTMB) for helpful discussions during the course of this study. The authors thank Dr. Robert Tesh at the World Reference Center of Emerging Virus and Arboviruses (WRCEVA) from UTMB for providing ZIKV PRVABC59 strain and ZIKV-specific hyper-immune ascitic fluid. P.-Y.S. lab was supported by NIH grants U19AI142759, AI127744, Clinical and Translational Science Award UL1TR001439, the Kleberg Foundation Award, John S. Dunn Foundation, Amon G. Carter Foundation,  Summerfield Robert Foundation, and CDC grant U01CK0000512 for the Western Gulf Center of Excellence for Vector-Borne Diseases. This research was also supported by the World Reference Center for Emerging Viruses and Arboviruses, NIH grant AI120942 to S.C.W. T.W. was supported by NIH grants R01 AI099123 and R01 AI27744, and a grant from Sealy Institute for Vaccine Sciences at UTMB.</p>
</ack>
